Home-based monitoring of persons with advanced Parkinson’s disease using smartwatch-smartphone technology

Tsviya Fay-Karmon, Noam Galor, Benedetta Heimler, Asaf Zilka, Ronny P. Bartsch, Meir Plotnik, Sharon Hassin-Baer

Research output: Contribution to journalArticlepeer-review

Abstract

Movement deterioration is the hallmark of Parkinson’s disease (PD), characterized by levodopa-induced motor-fluctuations (i.e., symptoms’ variability related to the medication cycle) in advanced stages. However, motor symptoms are typically too sporadically and/or subjectively assessed, ultimately preventing the effective monitoring of their progression, and thus leading to suboptimal treatment/therapeutic choices. Smartwatches (SW) enable a quantitative-oriented approach to motor-symptoms evaluation, namely home-based monitoring (HBM) using an embedded inertial measurement unit. Studies validated such approach against in-clinic evaluations. In this work, we aimed at delineating personalized motor-fluctuations’ profiles, thus capturing individual differences. 21 advanced PD patients with motor fluctuations were monitored for 2 weeks using a SW and a smartphone-dedicated app (Intel Pharma Analytics Platform). The SW continuously collected passive data (tremor, dyskinesia, level of activity using dedicated algorithms) and active data, i.e., time-up-and-go, finger tapping, hand tremor and hand rotation carried out daily, once in OFF and once in ON levodopa periods. We observed overall high compliance with the protocol. Furthermore, we observed striking differences among the individual patterns of symptoms’ levodopa-related variations across the HBM, allowing to divide our participants among four data-driven, motor-fluctuations’ profiles. This highlights the potential of HBM using SW technology for revolutionizing clinical practices.

Original languageEnglish
Article number9
JournalScientific Reports
Volume14
Issue number1
DOIs
StatePublished - 2 Jan 2024

Bibliographical note

Publisher Copyright:
© 2024, The Author(s).

Funding

We would like to thank our participants for their time and commitment to this process. Without them this work would have obviously not been possible. The study was funded by Abbvie.

FundersFunder number
AbbVie

    Fingerprint

    Dive into the research topics of 'Home-based monitoring of persons with advanced Parkinson’s disease using smartwatch-smartphone technology'. Together they form a unique fingerprint.

    Cite this